SEC Form 4 · accession 0001193125-26-295004
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Holger Weis
Officer — Chief Executive Officer
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 5:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2026 | A | 3,880 | $2.26 | A | 16,552 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock issued in lieu of net salary.